Riskpilot← Back to searchSign inGet full accessCellterm AB
ABActiveOrg 5569451361Hallarydsvägen 60Manufacture of plastic plates, sheets, tubes and profiles · NACE 2221Est. 20131-4 employees
Revenue 2024
SEK 64,2M
+3% vs 2023
EBITDA margin
-3.2%
+60% vs 2023
Equity ratio
17.2%
Financial strength
Net profit 2024
SEK -3,4M
+38% vs 2023
| Revenue | SEK 64,2M | +3% |
| EBITDA | SEK -2,1M | +60% |
| Net profit | SEK -3,4M | +38% |
| Total assets | SEK 38,9M | -7% |
| Equity | SEK 6,7M | -34% |
| Employees | — | — |
Legal name
Cellterm AB
Org number
5569451361
Legal form
Aktiebolag
NACE code
2221 · Manufacture of plastic plates, sheets, tubes and profiles
Founded
11 oktober 2013
Share capital
SEK 6 500 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av Nieminen, Henri Pie, Tom Göran Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva produktion av byggmaterial och därmed förenlig verksamhet.
Address
Hallarydsvägen 60
Email
info@cellterm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 60 393 | 63 211 | 64 500 | 56 253 | 82 332 | 91 847 | 62 593 | 64 189 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 14 | 4 029 | 1 401 | 3 019 | 7 342 | 8 599 | 5 741 | 989 | −5 123 | −2 064 |
| Depreciation & amort. | −1 025 | −1 111 | −1 127 | −1 237 | −1 225 | −1 152 | −1 144 | −1 157 | −1 119 | −1 437 |
| EBIT | −1 011 | 2 918 | 274 | 1 782 | 6 117 | 7 447 | 4 597 | −168 | −6 242 | −3 501 |
| Net financials | −478 | −423 | −423 | −388 | −296 | −169 | −135 | 1 | −343 | −1 337 |
| Profit before tax | −1 489 | 2 494 | −150 | 894 | 121 | 7 277 | 4 462 | −167 | −5 486 | −3 401 |
| Tax | −0 | −0 | −0 | −0 | −27 | −1 562 | −924 | −0 | −0 | −0 |
| Net profit | −1 489 | 2 494 | −150 | 894 | 94 | 5 715 | 3 538 | −167 | −5 486 | −3 401 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 19 306 | 19 023 | 24 074 | 21 887 | 22 961 | 29 624 | 34 724 | 30 574 | 42 063 | 38 925 |
| Equity | 5 180 | 7 674 | 7 525 | 8 419 | 6 513 | 12 228 | 15 766 | 15 599 | 10 113 | 6 712 |
| Long-term debt | 9 026 | 7 541 | 8 328 | 6 998 | 4 502 | 3 770 | 3 040 | 2 371 | 13 467 | 18 784 |
| Short-term debt | 5 100 | 3 808 | 8 222 | 5 970 | 5 746 | 7 426 | 9 718 | 6 404 | 13 381 | 9 764 |
| Total debt | 14 126 | 11 349 | 16 550 | 12 968 | 10 248 | 11 196 | 12 758 | 8 775 | 26 848 | 28 548 |
EBITDA margin
-3.2%
This company
15.8%
Market median
-120% vs market
20152024
Equity ratio
17.2%
This company
38.2%
Market median
-55% vs market
20152024
Return on equity
-50.7%
This company
18.4%
Market median
-376% vs market
20152024
Net profit margin
-5.3%
This company
8.1%
Market median
-165% vs market
20152024
Asset turnover
1.65×
This company
1.12×
Market median
+47% vs market
20152024
Debt / equity
4.80×
This company
0.62×
Market median
-674% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HT Audit | Audit | 2020 | — | — |
DA Chief Auditor | Chief Auditor | 2023 | — | — |
TG External Signatory | External Signatory | 2026 | — | — |
KK Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cellterm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Tobias Edfors | Audit | 0 companies |
| Daniel Andreas Magnusson | Chief Auditor | 0 companies |
| Tom Göran Pie | External Signatory | 0 companies |
| Karl Kristian Helmer | Chief Executive Officer | 0 companies |
| John Peter Borneskog | Board of Directors | 0 companies |
| Lars Ulf Dornerus | Chairman | 0 companies |
| Ellinor Jenny Louise Andersson | Deputy Board Member | 0 companies |
| Christian Dangl | Board of Directors | 0 companies |
| Asso Ulf Niklas Erävuoma | Board of Directors | 0 companies |
| Teppo Nieminen | Board of Directors | 0 companies |
| Henri Nieminen | Chairman | 0 companies |